Acreage Reports First Quarter 2023 Financial Results
Achieved Ninth Consecutive Quarter of Positive Adjusted EBITDA Received Shareholder Approval for Strategic Arrangement with Canopy and Canopy
Achieved Ninth Consecutive Quarter of Positive Adjusted EBITDA Received Shareholder Approval for Strategic Arrangement with Canopy and Canopy
Endexx Consolidated Q2 Year-over-Year Quarterly Sales Increased 865% CAVE CREEK, AZ, May 22, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –
TerrAscend Debuts Legend in the Great Lakes State TORONTO, May 19, 2023 /CNW/ – TerrAscend Corp. (“TerrAscend” or the “Company”)
This visit represents a continuation of the government’s support for PLC, its partnership with the NASA Indigenous Community, and approach to
Known for Canada’s #1 cannabis conferences, Lift’s U.S. debut welcomes all members of the cannabis industry and community for three days of
Revenue Increased 26.9% to $24.1 Million; Gross Profit Increased 51.9% to $4.5 Million; Net Loss of $3.3 Million for the Quarter, up from a $1.0
Integration With Point-of-Sale Will Improve the User Experience for Cannabis-Related Businesses Using Green Check Platform BONITA SPRINGS, FL, May
Flora generated $20.1 million in revenue in Q1 2023, a 307% increase year-over-year. Gross profit for Q1 2023 increased 105% year-over-year, to $5.5
Synergy targets related to the Valens acquisition increased to more than $30 million through 2024 CALGARY, AB, May 15, 2023 /PRNewswire/ –
Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is
News provided by Clearmind Medicine, May 12, 2023 IMCA medical center’s ethics committee approves clinical trial using proprietary CMND-100
TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today reported its
Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis
1606 Corp. (OTC: CBDW), an acquisition-based CBD holding company today announced that production of $150,000 in new inventory has been ordered to
MindBio clinical trial published in Peer Reviewed Paper Biological Psychiatry First of 8 significant publications on LSD-Microdosing from a Phase 1